Off the wire
• EC proposes to boost mobile internet services with high-quality radio frequencies  • United Nations World Tourism Organization issues statement on Zika virus  • Industrial producer prices down 0.8 pct in eurozone, EU in December  • Nigeria says global oil prices drop not to derail 2016 budget  • Syrian opposition accuses gov't, Russian actions as threat to current peace talks  • UN Envoy to invite Syrian women and civil society representatives to talks  • China's new wind power capacity hits record high  • White House announces steps to boost U.S. resilience to earthquakes  • Spotlight: Syria peace talks in Geneva struggle to continue into second day  • 44 H7N9 human cases reported in mainland in past five months  
You are here: 　 Home

French drug maker Sanofi launches searches for Zika vaccine

Xinhua, February 3, 2016 Adjust font size:

French pharmaceutical company Sanofi announced Tuesday the launching of a project to research and develop a vaccine against Zika virus (ZIKV) amid growing disease fears.

Via its vaccines division, Sanofi Pasteur, the drug maker said to use its expertise in developing vaccines for similar viruses such as yellow fever, Japanese encephalitis and, most recently, dengue.

"Established research and industrial infrastructure for the newly licensed vaccine for dengue, Dengvaxia, can be rapidly leveraged to help understand the spread of ZIKV and potentially speed identification of a vaccine candidate for further clinical development,", it added in a press release.

"Sanofi Pasteur is responding to the global call to action to develop a Zika vaccine given the disease's rapid spread and possible medical complications," says Dr. Nicholas Jackson, Global Head of Research for Sanofi Pasteur.

During an emergency meeting, the World Health Organization (WHO) on Monday declared an international public health emergency due to Zika's worrying spread and link to thousands of recent birth defects in Brazil.

Mosquito-borne Zika virus has symptoms including fever, muscle and joint pain, headache, nausea and rash. Affecting pregnant women, the virus could cause " microcephaly results in an abnormally small head impairing brain development."

Currently, there is no vaccine or specific treatment for Zika. The World Health Organization said expecting 3.4 million of Zika cases. Endit